Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
BTCS Provides Corporate Update and 2016 Outlook
-
Chardan Capital Cautious on Esperion (ESPR) Partnership Ahead of Phase 3 Data
-
Joseph Gonnella Retires as CEO for Enerpulse Technologies
-
Premier Biomedical Announces $1.6mil Financing ā Consolidates Funding Needs Through 2016
-
Orbital Tracking Corp. Completes $1.1 Million Private Placement
-
Chardan Capital Lifts PT on REGENXBIO (RGNX) to $35 Amid New FDA RPD Designation for RGX-111
-
Chardan Capital Trims PT on StemCells (STEM) to $1 Amid Capital Preservation Plans
-
Notable Analyst Rating Changes 12/23: (EEFT) (OKE) (DLPH) Upgraded; (MU) (BBBY) (SCS) Downgraded
-
Chardan Capital Markets Starts Eyegate Pharmaceuticals (EYEG) at Buy
-
Chardan Capital Initiates Coverage on Spark Therapeutics (ONCE) at Neutral
-
TiGenix (TIG) Files for U.S. IPO; Plans to List on Nasdaq Global Market
-
TiGenix files Registration Statement for proposed initial public offering in the United States
-
TiGenix files Registration Statement for proposed initial public offering in the United States
-
Streetinsider.com's Hot Lunchtime Reads 12/21: (AAPL) (TSLA) (LBIO) (PAA) (MSFT)
-
Chardan Capital Reaffirms Lion Biotech (LBIO) at 'Buy'; TILs Expected to be Tested in Variety of Cancer Settings
-
Chardan Capital Markets Starts Skyworks Solutions (SWKS) at Buy
-
Pre-Open Stock Movers 12/14: (AKBA) (DEST) (TSL) Higher; (ATRA) (NWL) (GPRO) Lower (more...)
-
Chardan Capital Lifts PT on Ophthotech (OPHT) to $200; Notes Recent Upgrades to Fovista
-
Chardan Capital Markets Starts Voyager Therapeutics (VYGR) at Sell
-
UPDATE: Chardan Capital Markets Starts CalAmp Corp. (CAMP) at Buy
-
Chardan Capital No Longer Expects Underperformance from Orexigen Therapeutics (OREX)
-
Soft Wearables Segment Pressures Ambarella (AMBA) Results; China IP Remains on Watch - Chardan Capital
-
Implant Sciences to Explore Strategic Options as Growing Security Needs for Soft Targets Drives Spending on Security Technologies
-
Unusual 11 Mid-Day Movers 12/2: (ONDK) (MTSN) (ADMP) Higher; (ZFGN) (OGXI) (ATV) Lower
-
Chardan Capital Markets Starts Ritter Pharmaceuticals (RTTR) at Buy
-
Giggles Nā Hugs Signs Agreement with New York-Based Chardan Capital Markets
-
Chardan Capital Says uniQure (QURE) on Pullback, Slight Delay to AMT-060 is Immaterial
-
MTBC Announces Closing of $5.8 Million Series A Cumulative Redeemable Perpetual Preferred Stock Offering and Exercise of Over-Allotment Option by Underwriters
-
MTBC Announces Closing of $5.8 Million Series A Cumulative Redeemable Perpetual Preferred Stock Offering and Exercise of Over-Allotment Option by Underwriters
-
Chardan Capital Remains Buyers of Energous (WATT) Amid Equity Raise
-
Unique Fabricating, Inc. Reports Third Quarter Revenues of $39.6 Million; Adjusted Diluted Earnings per Share of $0.18
-
Chardan Capital Positive on YOU On Demand (YOD) Deal with Ai Shang Media; Affirms at 'Buy'
-
MTBC Reports Third Quarter 2015 Results
-
MTBC Reports Third Quarter 2015 Results
-
Medicines Co. (MDCO), Alnylam' (ALNY) ALN-PCSsc Data Affirm Potential bi-Annual Dose Regimen - Chardan Capital
-
Live Ventures (LIVE) Terminates ATM Engagement Agreement
-
Vascular Biogenics Ltd. Announces Closing of $15 Million Underwritten Offering of Ordinary Shares and Warrants
-
Unusual 11 Mid-Day Movers 11/4: (EFOI) (MXL) (GHDX) Higher; (ENPH) (FARO) (GRPN) Lower
-
Chardan Capital Markets Starts Opexa Therapeutics (OPXA) at Buy
-
Chardan Capital Markets Starts The Medicines Company (MDCO) at Buy
-
Chardan Capital Markets Upgrades Perion Network Ltd. (PERI) to Buy
-
MTBC Announces Pricing of Series A Cumulative Redeemable Perpetual Preferred Stock Offering
-
MTBC Announces Pricing of Series A Cumulative Redeemable Perpetual Preferred Stock Offering
-
CEVA (CEVA) PT Bumped to $27 at Chardan Capital Markets
-
Genius Brands International Announces $4.3 Million Private Placement
-
Integrated Device Technology (IDTI) PT Raised to $34 at Chardan Capital Markets
-
Vascular Biogenics (VBLT) PT Raised to $27.50 at Chardan Capital Markets
-
WaferGen Bio-systems Announces Successful Completion of $17.25 Million Public Offering
-
Chardan Capital Markets Starts Regenxbio Inc. (RGNX) at Buy
-
Blue Earth (BBLU) Enters $4M Registered Direct Offering of Common Stock, Warrants

